You are here

Lexington Biosciences Inc.

Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
LNB
CSE Index: 
Currency: 

Lexington Biosciences, Inc. is a development stage medical device company operating within the healthcare industry. Lexington is focused on development and commercialization of non-invasive cardiovascular health monitoring products to allow predictive diagnosis of future cardiovascular events. The current focus of the company is to develop and market the HeartSentry endothelial function measurement product.

You are here

Lexington Biosciences Inc. (LNB)

SEDAR Information

Company Info

Address
1055 West Hastings Street
Suite 1900
Vancouver, BC V6E 2E9
Canada
Phone
(800) 320-2640
Email
info@lexingtonbiosciences.com
Listing date
Tuesday, May 9, 2017
Transfer Agent
AST Trust Company (Canada)

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
37,853,401
Reserved for Issuance: 
3,227,400

Bulletins

05/05/2017

2017-0507 - New Listing - Lexington Biosciences Inc. (LNB)

May 5, 2017

The common shares of Lexington Biosciences Inc. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com

Advertisement

Publicité

Latest CSE News

Upcoming Events

04_23_Arcview_Vancouver_Investor_Forum_Website

Arcview Vancouver Investor Forum

Tuesday, April 23, 2019 (All day) to Thursday, April 25, 2019 (All day)
04_24_Blockchain_Revolution_Global_Conference_Website

Blockchain Revolution Global Conference

Wednesday, April 24, 2019 (All day) to Thursday, April 25, 2019 (All day)
04_24_CSE_Grit_Capital_Present_eSports_Website_v2

CSE & Grit Capital Present: eSports in the Capital Markets

Wednesday, April 24, 2019 -
5:00pm to 7:00pm